ArticleOncology research2019

Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway.

Yulong Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.